Amyotrophic Lateral Sclerosis [clinicaltrials_resource:0d5f6df81587b7b461abb3f1f6960a99]
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00004457]Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease [clinicaltrials:NCT00004771]Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS] [clinicaltrials:NCT00005674]Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00005766]Amyotrophic Lateral Sclerosis (ALS) Gulf War Study [clinicaltrials:NCT00007722]Exogenous Toxicants and Genetic Susceptibility in ALS [clinicaltrials:NCT00011154]Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS [clinicaltrials:NCT00021697]Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00023075]clinicaltrials:NCT00035815A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00036413]Minocycline to Treat Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00047723]Creatine for the Treatment of Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00070993]Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00072709]clinicaltrials:NCT00107770Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV) [clinicaltrials:NCT00116558]Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00125203]Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00136110]Clinical Research in ALS [clinicaltrials:NCT00136500]R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00140218]Phase II Study Using Thalidomide for the Treatment of ALS [clinicaltrials:NCT00140452]Amyotrophic Lateral Sclerosis and Frontotemporal Dementia [clinicaltrials:NCT00159198]The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00160004]Study of the Effects Strengthening Exercises in Individuals With ALS [clinicaltrials:NCT00204464]A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00213824]A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS) [clinicaltrials:NCT00230074]clinicaltrials:NCT00243932Influence of G-CSF and EPO on Associative Learning and Motor Skills [clinicaltrials:NCT00298597]Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org [clinicaltrials:NCT00302198]The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study [clinicaltrials:NCT00317616]clinicaltrials:NCT00324454Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00326625]Mitochondrial Functions and Oxidative Stress in ALS Patients [clinicaltrials:NCT00331812]Effects of Gastrostomy on Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00337402]Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00339976]clinicaltrials:NCT00349622Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS) [clinicaltrials:NCT00353665]clinicaltrials:NCT00355576clinicaltrials:NCT00372879Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort [clinicaltrials:NCT00377351]Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement [clinicaltrials:NCT00386464]
condition [clinicaltrials_vocabulary:condition]
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00004457]Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease [clinicaltrials:NCT00004771]Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS] [clinicaltrials:NCT00005674]Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00005766]Amyotrophic Lateral Sclerosis (ALS) Gulf War Study [clinicaltrials:NCT00007722]Exogenous Toxicants and Genetic Susceptibility in ALS [clinicaltrials:NCT00011154]Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS [clinicaltrials:NCT00021697]Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00023075]clinicaltrials:NCT00035815A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00036413]Minocycline to Treat Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00047723]Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00069186]Creatine for the Treatment of Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00070993]Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00072709]National Registry of Veterans With Amyotrophic Lateral Sclerosis and DNA Bank [clinicaltrials:NCT00076154]clinicaltrials:NCT00107770Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV) [clinicaltrials:NCT00116558]Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00125203]Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00136110]Clinical Research in ALS [clinicaltrials:NCT00136500]R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00140218]Phase II Study Using Thalidomide for the Treatment of ALS [clinicaltrials:NCT00140452]Amyotrophic Lateral Sclerosis and Frontotemporal Dementia [clinicaltrials:NCT00159198]The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00160004]Study of the Effects Strengthening Exercises in Individuals With ALS [clinicaltrials:NCT00204464]A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00213824]Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS] [clinicaltrials:NCT00214110]A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS) [clinicaltrials:NCT00230074]Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00231140]clinicaltrials:NCT00243932A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS [clinicaltrials:NCT00244244]Influence of G-CSF and EPO on Associative Learning and Motor Skills [clinicaltrials:NCT00298597]Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org [clinicaltrials:NCT00302198]The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study [clinicaltrials:NCT00317616]clinicaltrials:NCT00324454Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00326625]Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00330681]Mitochondrial Functions and Oxidative Stress in ALS Patients [clinicaltrials:NCT00331812]Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00334516]Effects of Gastrostomy on Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00337402]
condition browse [clinicaltrials_vocabulary:condition-browse]
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00004457]Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease [clinicaltrials:NCT00004771]Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS] [clinicaltrials:NCT00005674]Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00005766]Amyotrophic Lateral Sclerosis (ALS) Gulf War Study [clinicaltrials:NCT00007722]Exogenous Toxicants and Genetic Susceptibility in ALS [clinicaltrials:NCT00011154]Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS [clinicaltrials:NCT00021697]Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00023075]clinicaltrials:NCT00035815A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00036413]Minocycline to Treat Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00047723]Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00069186]Creatine for the Treatment of Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00070993]Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00072709]National Registry of Veterans With Amyotrophic Lateral Sclerosis and DNA Bank [clinicaltrials:NCT00076154]clinicaltrials:NCT00107770Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV) [clinicaltrials:NCT00116558]Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00125203]Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00136110]Clinical Research in ALS [clinicaltrials:NCT00136500]R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00140218]Phase II Study Using Thalidomide for the Treatment of ALS [clinicaltrials:NCT00140452]Amyotrophic Lateral Sclerosis and Frontotemporal Dementia [clinicaltrials:NCT00159198]The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00160004]Study of the Effects Strengthening Exercises in Individuals With ALS [clinicaltrials:NCT00204464]A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00213824]Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS] [clinicaltrials:NCT00214110]A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS) [clinicaltrials:NCT00230074]Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00231140]clinicaltrials:NCT00243932A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS [clinicaltrials:NCT00244244]Influence of G-CSF and EPO on Associative Learning and Motor Skills [clinicaltrials:NCT00298597]Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org [clinicaltrials:NCT00302198]The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study [clinicaltrials:NCT00317616]clinicaltrials:NCT00324454Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00326625]Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00330681]Mitochondrial Functions and Oxidative Stress in ALS Patients [clinicaltrials:NCT00331812]Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00334516]Effects of Gastrostomy on Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00337402]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Amyotrophic Lateral Sclerosis [clinicaltrials_resource:0d5f6df81587b7b461abb3f1f6960a99]
Bio2RDF identifier
0d5f6df81587b7b461abb3f1f6960a99
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0d5f6df81587b7b461abb3f1f6960a99
identifier
clinicaltrials_resource:0d5f6df81587b7b461abb3f1f6960a99
title
Amyotrophic Lateral Sclerosis
@en
type
label
Amyotrophic Lateral Sclerosis [clinicaltrials_resource:0d5f6df81587b7b461abb3f1f6960a99]
@en
Amyotrophic Lateral Sclerosis